Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer

Clinical trial NCT06085755 · RECRUITING

Trial details

NCT number: NCT06085755
Sponsor: Jeeyun Lee
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stomach Neoplasm

Start date: 2024-09-30
Primary completion: 2025-12-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.